$COR News

Is Cencora’s New CFO, $2 Billion Buyback, and Lawsuit Trio Altering The Investment Case For Cencora (COR)?

Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer

Cencora Appoints Eva C. Boratto As EVP And CFO

If You Invested $100 In Cencora Stock 10 Years Ago, You Would Have This Much Today

Cencora Announces Updated Fiscal Year 2026 Financial Outlook

Cencora Raises FY26 Adjusted EPS Range From $17.65 - $17.90 To $17.70 - $17.90; Announces $2B Buyback Plan

Cencora (COR) Emerges as a Healthcare Leader with Robust Fundamentals and Strategic Re-Rating

Cencora Legal Probes Test Investor Confidence After Weaker Q2 Revenue Outlook

The Top 5 Analyst Questions From Cencora’s Q1 Earnings Call

Are Wall Street Analysts Bullish on Cencora Stock?

Cencora, Inc. (COR) Presents at BofA Securities 2026 China Conference Transcript

Cencora, Inc. (COR) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Wells Fargo Maintains Overweight on Cencora, Lowers Price Target to $331

Cencora Q2 Earnings Call Highlights

UBS Maintains Buy on Cencora, Raises Price Target to $412

Citigroup Maintains Buy on Cencora, Lowers Price Target to $355

Is Cencora (COR) Prioritizing Margin Expansion Over Growth With Its Raised EPS Outlook and Buybacks?

Cencora Earnings Review: The Selloff Was Overdone In My View

Evercore ISI Group Maintains Outperform on Cencora, Lowers Price Target to $300

Baird Maintains Outperform on Cencora, Lowers Price Target to $339